These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12138274)

  • 1. Renal proximal tubular metabolism of protein-linked pentosidine, an advanced glycation end product.
    Asano M; Fujita Y; Ueda Y; Suzuki D; Miyata T; Sakai H; Saito A
    Nephron; 2002 Aug; 91(4):688-94. PubMed ID: 12138274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal catabolism of advanced glycation end products: the fate of pentosidine.
    Miyata T; Ueda Y; Horie K; Nangaku M; Tanaka S; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 1998 Feb; 53(2):416-22. PubMed ID: 9461101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats.
    Waanders F; Greven WL; Baynes JW; Thorpe SR; Kramer AB; Nagai R; Sakata N; van Goor H; Navis G
    Nephrol Dial Transplant; 2005 Oct; 20(10):2060-70. PubMed ID: 15956058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
    Miyazaki K; Nagai R; Horiuchi S
    J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
    Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C
    J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
    Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
    Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
    Handa JT; Verzijl N; Matsunaga H; Aotaki-Keen A; Lutty GA; te Koppele JM; Miyata T; Hjelmeland LM
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):775-9. PubMed ID: 10067983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects.
    Odetti P; Fogarty J; Sell DR; Monnier VM
    Diabetes; 1992 Feb; 41(2):153-9. PubMed ID: 1733803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
    Horie K; Miyata T; Yasuda T; Takeda A; Yasuda Y; Maeda K; Sobue G; Kurokawa K
    Biochem Biophys Res Commun; 1997 Jul; 236(2):327-32. PubMed ID: 9240434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of furosine and pentosidine in CAPD patients.
    Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
    Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentosidine and its deposition in renal tissue in renal transplantation.
    Yoshida K; Yoneda T; Fujimoto K; Hirao Y; Konishi N
    Transplant Proc; 2005 Dec; 37(10):4266-72. PubMed ID: 16387094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pentosidine levels in uremic patients before and after hemodialysis.
    Takahashi M; Kushida K; Ishihara C; Denda M; Inoue T
    Scand J Urol Nephrol; 1995 Jun; 29(2):131-4. PubMed ID: 7569788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentosidine accumulates in the aging vitreous body: a gender effect.
    van Deemter M; Ponsioen TL; Bank RA; Snabel JM; van der Worp RJ; Hooymans JM; Los LI
    Exp Eye Res; 2009 Jun; 88(6):1043-50. PubMed ID: 19450456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease.
    Friedlander MA; Wu YC; Schulak JA; Monnier VM; Hricik DE
    Am J Kidney Dis; 1995 Mar; 25(3):445-51. PubMed ID: 7872323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.